Trial Profile
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2020
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms DUTCH-PEERS/TWENTE-2
- 12 Jul 2020 Results of pooled analysis from four trials (TWENTE I- TWENTE IV) published in the American Heart Journal
- 30 Aug 2017 Results assessing 4-year clinical safety and efficacy, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
- 03 Nov 2013 Results published in the Lancet.